These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7615987)

  • 1. Lymphocyte activation in cutaneous T-cell lymphoma.
    Wood GS
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):105S-109S. PubMed ID: 7615987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
    Wood GS
    Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin.
    Potoczna N; Boehncke WH; Nestle FO; Küenzlen C; Sterry W; Burg G; Dummer R
    J Cutan Pathol; 1996 Aug; 23(4):298-305. PubMed ID: 8864915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
    Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
    J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine epitheliotropic cutaneous T-cell lymphoma: an investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality.
    Moore PF; Affolter VK; Graham PS; Hirt B
    Vet Dermatol; 2009 Oct; 20(5-6):569-76. PubMed ID: 20178496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma.
    Bagot M; Echchakir H; Mami-Chouaib F; Delfau-Larue MH; Charue D; Bernheim A; Chouaib S; Boumsell L; Bensussan A
    Blood; 1998 Jun; 91(11):4331-41. PubMed ID: 9596682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma.
    Asadullah K; Friedrich M; Döcke WD; Jahn S; Volk HD; Sterry W
    J Invest Dermatol; 1997 May; 108(5):743-7. PubMed ID: 9129226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease.
    Borowitz MJ; Weidner A; Olsen EA; Picker LJ
    Leukemia; 1993 Jun; 7(6):859-63. PubMed ID: 7684799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
    Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
    Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemic T cells from patients with cutaneous T-cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T-cell antigen receptor complex.
    Hansen ER; Vejlsgaard GL; Cooper KD; Heidenheim M; Larsen JK; Ho VC; Ross CW; Fox DA; Thomsen K; Baadsgaard O
    J Invest Dermatol; 1993 May; 100(5):667-73. PubMed ID: 8098345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses.
    Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H
    Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.